A fluorescent aptamer sensor for detecting kanamycin content and a preparation method thereof
By splitting the fluorescent aptamer sensor that binds to DNA-AgNCs, the ExoⅠ enzyme cleavage reaction and DNA-AgNCs fluorescent probes solve the problems of insufficient sensitivity and high detection cost of the existing kanamycin detection methods. High sensitivity and selective detection in complex samples are achieved, with a detection limit of 1.46 nmol/L, which is suitable for samples such as milk and seawater.
Patent Information
- Application Number
- CN202410472230.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-04-19
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2044-04-19
AI Technical Summary
The existing kanamycin detection methods have insufficient sensitivity, high detection cost, expensive instruments, and poor detection effect on complex samples, making it difficult to achieve high sensitivity, high selectivity and high stability detection.
Using a fluorescent aptamer sensor that binds to DNA-AgNCs, a fluorescent aptamer can detect kanamycin in complex samples through the enzyme cleavage reaction of ExoⅠ and the fluorescent probe of DNA-AgNCs. The fluorescent aptamer sensor uses the characteristics of the split aptamer and the fluorescent properties of DNA-AgNCs to achieve high sensitivity detection of kanamycin.
It realizes high sensitivity and selective detection of kanamycin, with a detection limit of 1.46nmol/L, fast detection speed and low energy consumption. It is suitable for complex samples such as milk, seawater, etc., with high stability and low cost. Detection performance.
Smart Images

Figure CN118465253B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of biosensors, and in particular relates to a fluorescent aptamer sensor for detecting kanamycin content and a preparation method thereof. Background Art
[0002] Kanamycin is a broad-spectrum aminoglycoside antibiotic that was first isolated from Streptomyces. It has the function of preventing bacterial protein formation and is often used as a protein biosynthesis inhibitor. Kanamycin can cause misreading of the mRNA code by binding to the 30s ribosome. If an enzyme that destroys kanamycin is produced in bacteria, it will become a resistant strain. Kanamycin-resistant plasmids are often used as selection genes or marker genes in molecular cloning. Because kanamycin has a broad-spectrum antibacterial property and has a strong and lasting effect on Gram-negative bacteria, it is widely used because of its low price, convenient medication, and excellent effect. Kanamycin can not only treat various infectious diseases in agriculture, animal husbandry, and aquaculture, but also promote the growth of livestock and poultry, thereby improving economic benefits. However, the irrational use of kanamycin will cause the residues of kanamycin in animal-derived foods such as milk to enter the human body through food enrichment, causing varying degrees of damage to the human body, accompanied by potential harm to public health and the environment. Excessive kanamycin has potential nephrotoxicity and ototoxicity in animals and humans, causing neuromuscular blockade, allergic reactions, bacterial tolerance, dysbacteriosis, fermentation abnormalities and other toxic effects. Therefore, it is of great significance to seek a kanamycin detection method that is simple to operate, portable, specific, sensitive, and does not require expensive instruments to strengthen the monitoring of kanamycin residues in animal-derived foods and ensure food safety.
[0003] Currently, researchers have developed a variety of methods to detect kanamycin, including gas chromatography (GC), liquid chromatography (LC), high performance liquid chromatography (HPLC), liquid chromatography-mass spectrometry (LC-MS), enzyme-linked immunosorbent assay (ELISA), etc. In recent years, in order to improve the detection limit of trace kanamycin, researchers have made increasing efforts to develop more sensitive detection technologies.
[0004] Aptamers are oligonucleotide sequences with high affinity and specificity for target substances obtained by screening from random oligonucleotide libraries based on exponential enrichment system evolution technology (SELEX). Compared with antibodies, aptamers have the advantages of easy synthesis, modification and repair, reusability and long-term storage. Therefore, aptamers are mostly used as recognition elements to construct aptamer sensors. Aptamers can be divided into optical aptamer biosensors, electrochemical aptamer sensors and photoelectrochemical aptamer sensors according to the different sensor signal elements. Aptamers are widely used in the detection of biological components such as cells, viruses, proteins, toxins, and allergens due to their unique advantages and extraordinary sensitivity. Recently, researchers have found that long-chain aptamers are easy to fold into non-specific structures, which makes it difficult to identify the target. Splitting the long-chain complete aptamer into two or more aptamer fragments can stabilize the aptamer structure and reduce its flexibility, which is helpful for the recognition of the target. Split aptamers can jointly recognize the target to solve the false positive problem caused by the flexible structure of the aptamer. In addition, split aptamers can enrich the design types of aptamer sensors and make it possible to design highly sensitive sandwich aptamer sensors.
[0005] Exonuclease I (ExoⅠ) can degrade single-stranded DNA in the 3'→5' direction, releasing deoxyribonucleoside 5'-monophosphate in a stepwise manner, leaving the 5'-terminal dinucleotide intact, and will not cut the DNA chain whose terminal 3'-OH group is blocked by a phosphoryl or acetyl group. Due to the special properties of this enzyme, it has considerable application prospects in the fields of analytical chemistry and molecular biology.
[0006] In the process of constructing aptamer sensors, the use of new nanoprobes can often make the detection system more sensitive and sophisticated. In recent years, researchers have developed many new fluorescent probes to construct fluorescent aptamer sensors. Among them, DNA silver nanoclusters (DNA-AgNCs) are an emerging fluorescent nanoprobe with fluorescent properties synthesized using DNA as a template. Compared with conventional organic dyes and quantum dots, they have the advantages of high quantum yield, strong photostability, low preparation cost and simple synthesis method. In addition, DNA-AgNCs have low toxicity and will not produce fluorescent flickering. Therefore, DNA-AgNCs are often regarded as a strong competitor to conventional fluorescent dyes. In the process of synthesizing DNA-AgNCs, Ag + Combined with the purine N7 and pyrimidine N3 of the DNA base, theoretically, four base pairs of Ag +The affinity follows the order of cytosine (C) > guanine (G) > adenine (A) > thymine (T). Therefore, polycytosine is usually used as a template for the synthesis of DNA-AgNCs. Furthermore, researchers have found that DNA-AgNCs with different emission wavelengths can be easily prepared by adjusting the base composition or length of the synthetic template sequence. At the same time, the change in the secondary structure of the DNA-AgNCs fluorescent probe caused by hybridization or molecular complexation with complementary sequences will also lead to a shift in the emission wavelength or a sharp increase or decrease in the fluorescence intensity. Based on this characteristic, DNA-AgNCs have been used to construct a variety of biosensors for the detection of various antibiotics, heavy metal ions, biological toxins and other substances. Nowadays, the synthesis of AgNCs using DNA as a template has attracted the attention of more and more researchers and has gradually become a reliable nano-fluorescent probe in the construction of biosensors. Summary of the invention
[0007] The purpose of the present invention is to propose a fluorescent aptamer sensor for detecting the content of kanamycin and a preparation method thereof, which can achieve high-sensitivity and high-selectivity detection of kanamycin in complex samples, with a minimum detection limit of 1.46 nmol / L. The detection procedure of the present invention can be completed within 5 hours, the detection process is easy to control, low energy consumption, the prepared DNA-AgNCs have good reproducibility, the actual detection sample does not require a cumbersome pretreatment process, and the technical requirements for the experimenter are not high, thereby achieving a balance between detection cost and detection efficiency.
[0008] In order to achieve the above object, the technical solution adopted by the present invention is as follows:
[0009] A fluorescent aptamer sensor for detecting kanamycin content and a preparation method thereof. The kanamycin fluorescent aptamer sensor is prepared by using two split aptamers as recognition probes and ExoⅠ as a quencher, and synthesizing a DNA-AgNCs signal probe. The kanamycin split aptamer sequence is shown in SEQ ID NO.1, and the sequence SEQ ID NO.1 is specifically: Split-Apt-Ⅰ: 5'-TGGGGGTTGAG-3'; Split-Apt-Ⅱ: 5'-GCTAAGCCGA-3'.
[0010] Furthermore, the dosage of the DNA-AgNCs is 1.4 μmol / L, the dosage of ExoⅠ is 25 U, the enzyme cleavage temperature of ExoⅠ is 37° C., and the enzyme cleavage time is 35 min.
[0011] A method for preparing a fluorescent aptamer sensor for detecting kanamycin content comprises the following steps:
[0012] (1) Preparation of DNA stock solution:
[0013] Balance the centrifuge tube containing DNA powder and place it in the centrifuge for centrifugation. After the centrifugation is completed, gently take out the centrifuge tube and open the lid. Add a certain amount of double distilled water according to the instructions on the tube wall and shake it thoroughly to make the DNA powder fully dissolved. Accurately quantify the DNA sample solution to 100 μmol / L and store it in a 4°C refrigerator for later use.
[0014] (2) Hybridization complementation between Split-Apt-Ⅰ and cDNA-AgNCs sequences: Take the cDNA-Apt-Ⅰ mother solution and the Split-Apt-Ⅰ mother solution, mix them evenly, dissolve them in an appropriate amount of TE buffer, vortex and react for a period of time, and cool them down to form dsDNA.
[0015] (3) Recognition reaction of Split-Apt-Ⅰ and Split-Apt-Ⅱ with kanamycin: Take an appropriate amount of Split-Apt-Ⅱ mother solution, dissolve it in TE buffer, i.e. Tris-EDTA buffer (10mmol / L Tris, 1mmol / L EDTA), heat it in a metal bath for denaturation, and immediately transfer it to the dsDNA solution in (2) after the ice bath ends. At the same time, add diluted kanamycin solutions of different concentrations and mix and incubate.
[0016] (4) Enzyme digestion reaction of ExoⅠ: Take an appropriate amount of ExoⅠ and add it to the above mixed solution for enzyme digestion reaction. After the incubation, inactivate the enzyme at high temperature and then anneal at low temperature.
[0017] (5) Synthesis of DNA-AgNCs fluorescent probe: First, add an appropriate amount of silver nitrate (AgNO 3 ) solution, shake and mix well, then place in an ice bath, and then add sodium borohydride (NaBH 4 ) solution, shake and mix evenly, and then protect from light for reaction, so as to obtain DNA-AgNCs fluorescent probe, and complete the construction of kanamycin fluorescent aptamer sensor based on DNA-AgNCs.
[0018] Furthermore, in step (1), the centrifuge tube containing the DNA powder is balanced and placed in a centrifuge, and the speed during centrifugation is set to 10000 rpm / min and the centrifugation time is 1 min.
[0019] Furthermore, in step (2), during the hybridization incubation of Split-Apt-I and cDNA-AgNCs sequence, the DNA denaturation temperature was set to 95° C. and the time was 5 min.
[0020] Furthermore, in step (2), the ice bath time should not be too long, and the temperature condition for forming the dsDNA structure is set to 37° C. and the incubation time is 2 h.
[0021] Furthermore, in step (3), the target incubation temperature is set to 37° C., and the incubation time is set to 40 min.
[0022] Furthermore, in step (4), the incubation temperature is set to 37° C., the incubation time is set to 35 min, and the ice bath time should not be too long.
[0023] Furthermore, in step (5), the pH of the buffer used in the system is determined to be 6.75, and the DNA substrate, AgNO 3 With NaBH 4 The concentration ratio is 1:6:6.
[0024] Furthermore, the concentration range of kanamycin is 0 nmol / L to 10 μmol / L.
[0025] Furthermore, the present invention can achieve sensitive detection of kanamycin through the specific enzymatic cleavage of ExoⅠ.
[0026] The present invention also includes the application of the fluorescent aptamer sensor for detecting kanamycin content in lake water, sea water, milk, oyster meat, etc., for detecting the kanamycin content in real samples, and determining the recovery rate and relative standard deviation to analyze the detection performance in actual samples.
[0027] The present invention has the following beneficial effects:
[0028] Compared with the existing technology, the present invention has the following advantages: the present invention obtains a kanamycin aptamer sensor with high sensitivity, high specificity and high stability for the first time. The present invention combines the selective enzymatic cleavage of ExoⅠ and the significant affinity of the split aptamer with kanamycin, and can detect the residual amount of kanamycin in complex samples with high sensitivity, high selectivity and high stability, and the minimum detection limit can reach 1.46nmol / L. Compared with other kanamycin detection methods, the kanamycin fluorescent aptamer sensor has the advantages of high sensitivity and fast detection speed, and can be applied to the detection of antibiotics in biomedicine. The present invention combines aptamer recognition technology with DNA-AgNCs to construct a sensing system in which the fluorescence of the system dynamically decreases as the kanamycin concentration increases, and is used for high-sensitivity and high-selectivity detection of kanamycin in complex samples. In addition, the present invention further proves the feasibility of kanamycin split aptamers, and further deepens the application potential of kanamycin nucleic acid aptamers. BRIEF DESCRIPTION OF THE DRAWINGS
[0029] Figure 1 It is the detection principle diagram.
[0030] Figure 2 It is the fluorescence response diagram of the sensor at different target concentrations.
[0031] Figure 3 It is the sensor detection standard curve. DETAILED DESCRIPTION
[0032] The present invention will be further described below in conjunction with the accompanying drawings:
[0033] A method for preparing a fluorescent aptamer sensor for detecting kanamycin content, wherein the detection principle is as follows Figure 1 As shown, first, three oligonucleotide chains were designed, two of which were kanamycin split aptamers: Split-Apt-Ⅰ and Split-Apt-Ⅱ. cDNA-AgNCs were designed to be partially complementary to Split-Apt-Ⅰ and partially serve as the substrate sequence for synthesizing DNA-AgNCs. The design of the DNA-AgNCs substrate sequence was based on relevant literature and was designed to emit red fluorescence.
[0034] The method for preparing a fluorescent aptamer sensor for detecting kanamycin content is characterized in that: the fluorescent sensor detects kanamycin residues in milk, which is usually interfered by the complex milk matrix; the specific DNA template can produce DNA-AgNCs in the visible red wavelength range, which will reduce the fluorescence interference of milk by avoiding the fluorescence signal generated by the inherent components of milk in a relatively short wavelength range. In addition, red fluorescence has relatively high penetrability, which can also reduce the impact of interfering substances.
[0035] Kanamycin can compete with Split-Apt-Ⅰ and Split-Apt-Ⅰ in the cDNA-AgNCs complex, and then open the double strand, causing the 3' end of the oligonucleotide to expose the ExoⅠ cleavage site. After the oligonucleotide is cleaved by ExoⅠ, free DNA fragments are formed, resulting in changes in the secondary structure of the fluorescent probe. Then, DNA-AptNCs are synthesized by chemical reduction, and the fluorescence intensity of the synthesized DNA-AgNCs probe is greatly weakened. The total amount of kanamycin is quantitatively analyzed according to the change in the fluorescence intensity of the added target.
[0036] The preparation method comprises the following steps:
[0037] (1) Preparation of DNA stock solution:
[0038] Balance the centrifuge tube containing DNA powder and place it in a centrifuge for centrifugation. Set the speed to 10000rpm / min and the centrifugation time to 1min. After the centrifugation is completed, gently take out the centrifuge tube and open the lid. Accurately add a certain amount of double distilled water according to the instructions on the tube wall and shake it thoroughly to fully dissolve the DNA powder. Accurately quantify the DNA sample solution to 100μmol / L and store it in a 4℃ refrigerator for later use.
[0039] (2) Hybridization complementation between Split-Apt-Ⅰ and cDNA-AgNCs sequences: cDNA-AgNCs mother solution and Split-Apt-Ⅰ mother solution were mixed and dissolved in an appropriate amount of TE buffer. The mixture was vortexed and reacted for a period of time. The mixture was cooled to form dsDNA. During the hybridization incubation between Split-Apt-Ⅰ and cDNA-AgNCs sequences, the DNA denaturation temperature was set at 95°C for 5 min. The ice bath time should not be too long. The temperature condition for forming the dsDNA structure was set at 37°C and the incubation time was 2 h.
[0040] (3) Recognition reaction of Split-Apt-Ⅰ and Split-Apt-Ⅱ with kanamycin: Take an appropriate amount of Split-Apt-Ⅱ mother solution, dissolve it in TE buffer, i.e. Tris-EDTA buffer (10mmol / L Tris, 1mmol / L EDTA), heat it in a metal bath for denaturation, and immediately transfer it to the dsDNA solution in (2) after the ice bath ends. At the same time, add diluted kanamycin solution of different concentrations and mix and incubate. The temperature during target incubation is set to 37°C, and the incubation time is set to 40min.
[0041] (4) Enzyme digestion reaction of ExoⅠ: Take an appropriate amount of ExoⅠ and add it to the above mixed solution for enzyme digestion reaction. After the incubation, inactivate the enzyme at high temperature and then anneal at low temperature.
[0042] (5) Synthesis of DNA-AgNCs fluorescent probe: First, add an appropriate amount of silver nitrate (AgNO 3 ) solution, shake and mix well, then place in an ice bath, and then add sodium borohydride (NaBH 4 ) solution, shake and mix well, and then protect from light to react, so as to obtain DNA-AgNCs fluorescent probe, and complete the construction of kanamycin fluorescent aptamer sensor based on DNA-AgNCs; the pH of the buffer used in the system is determined to be 6.75, the DNA substrate, AgNO 3 With NaBH 4 The concentration ratio is 1:6:6.
[0043] Furthermore, the concentration range of kanamycin is 0 nmol / L to 10 μmol / L.
[0044] Furthermore, the present invention can achieve sensitive detection of kanamycin through the specific enzymatic cleavage of ExoⅠ.
[0045] The nucleic acid sequences described in the following examples were purchased from Shanghai Shenggong Biotechnology Co., Ltd. The sequences of the aptamers and signal probes used in the examples of the present invention are shown in Table 1.
[0046] Table 1. Sequence Listing
[0047] name Sequence (5'--3') Split-Apt-Ⅰ TGGGGGTTGAG Split-Apt-Ⅱ GCTAAGCCGA cDNA-AgNCs CCTCCTTCCTCCCGTACCCCCAA
[0048] Example 1: Plotting of standard curve for aptamer sensor detection
[0049] Under the optimal detection conditions, the sensitivity of the aptamer sensor was evaluated. The fluorescence emission spectra of kanamycin at 0 nmol / L, 0.5 nmol / L, 5 nmol / L, 15 nmol / L, 25 nmol / L, 50 nmol / L, 100 nmol / L, 500 nmol / L, 1 μmol / L and 10 μmol / L at an excitation wavelength of 545 nm were recorded. The dynamic detection range of the aptamer sensor and the linear relationship between kanamycin concentration and fluorescence intensity were determined with the concentration of kanamycin as the horizontal axis and the fluorescence intensity as the vertical axis. The linear equation and the detection limit (LOD) of the aptamer sensor were obtained by calculation.
[0050] Detection procedure: 7 μL cDNA-AgNCs (100 μmol / L) and 7 μL Split-Apt-Ⅰ (100 μmol / L) were mixed and dissolved in 84 μL TE buffer. After vortexing, the mixture was denatured at 95°C for 5 min and then slowly cooled to form a double-stranded complementary pairing of cDNA-AgNCs and Split-Apt-Ⅰ by thermal denaturation and renaturation. 7 μL Split-Apt-Ⅱ (100 μmol / L) was taken and mixed with 20 μL TE buffer to form a hairpin structure HP in the same way, and then immediately transferred to the prepared cDNA / Apt-Ⅰ complex. 10 μL of diluted kanamycin solution of different concentrations was taken and mixed with the above cDNA / Apt-Ⅰ complex and hairpin probe HP, and incubated at 37°C for 40 min. Then, add 25U ExoⅠ to the above mixed solution and perform enzyme digestion at 37℃ for 35min. After the reaction, incubate at 80℃ for 5min to inactivate the enzyme and cool it in an ice bath.
[0051] The synthesis of DNA-AgNCs was performed according to the reported method with some adjustments. First, 1.5 μL of 3 mmol / L AgNO was added to the above mixed solution. 3 Solution, (oligo-stranded DNA and Ag + The molar ratio was 1:6), and the mixture was shaken vigorously for 5 min and then placed in an ice bath for 40 min. Then, 1.5 μL of 3 mmol / L NaBH 4 Solution (BH 4- :Ag + =1:1 add NaBH 4Solution), vortexed for 5 minutes to mix, wrapped the centrifuge tube with tin foil and reacted in an ice bath in the dark for 5 hours to obtain the DNA-AgNCs signal probe. Then, the fluorescence intensity of the reaction system was detected using the Infinite-M100PRO multifunctional microplate reader at an excitation wavelength of 545 nm and an emission wavelength of 620 nm. The excitation and emission slits were both 10 nm, and the automatic scanning speed was set to 2000 nm / min. The recovery rate and relative standard deviation (RSD) were calculated.
[0052] Depend on Figure 2 It can be seen that with the continuous increase of kanamycin concentration, the fluorescence intensity of the aptamer sensor shows a gradient downward trend. Figure 3 It shows that when the concentration of kanamycin is between 5 nmol / L and 50 nmol / L, the concentration of kanamycin is linearly related to the fluorescence intensity of the aptamer sensor, and the linear equation is: Y = -12.03X + 1483, where R 2 =0.9903, and the calculated limit of detection (LOD) is 1.46 nmol / L, which indicates that the aptamer sensor we constructed has excellent detection sensitivity and extremely low detection limit.
[0053] Example 2: Detection of aptamer sensors in actual samples
[0054] In order to investigate the detection ability of the fluorescent aptasensor in actual samples, the kanamycin content in real samples was detected by spiking real samples with kanamycin, and the recovery rate and relative standard deviation were measured to analyze the detection performance in actual samples.
[0055] First, we selected two aquaculture water samples, fresh water and seawater, for spike recovery experiments. The fresh water was taken from Jingsi Lake of Jiangsu Ocean University, and the seawater was taken from Liandao, Haizhou District, Lianyungang. The two aquaculture water samples were filtered multiple times using a 0.22μm sterile filter membrane before use to remove particulate matter, and then the pH of the water samples was adjusted to neutral with sodium acetate buffer. 10μL of water samples with different concentrations of kanamycin (final concentrations were 25nmol / L and 50nmol / L, respectively) were taken for spike recovery experiments.
[0056] Pretreatment of milk: Milk samples were purchased from a local supermarket. 20% acetic acid was added dropwise to 50 mL of the milk sample until its pH dropped to 4.6. The sample was then placed in a 45°C water bath for 20 min to precipitate casein, and then centrifuged at 10,000 rpm for 20 min to remove protein and fat coagulation. The supernatant was collected and filtered with a 0.22 μm filter membrane to remove lipids. The kanamycin solution was then added to the prepared milk supernatant and the experimental procedures were followed.
[0057] Pretreatment of oyster meat: Fresh oysters were purchased from the Lianyungang seafood market. The cleaned live oysters were taken out and crushed with a grinder. 5 g of the sample was added to 5 mL of ultrapure water and mixed. The collected supernatant was centrifuged at 10,000 rpm for 20 min, filtered with a 0.22 μm filter membrane to remove impurities, and the kanamycin standard solution was diluted with the obtained supernatant to obtain kanamycin solutions with final concentrations of 25 nmol / L and 50 nmol / L, and the fluorescence signal was measured by the sensor we constructed.
[0058] By analyzing the test results, we found that the recovery rate of the constructed fluorescent aptamer sensor in four actual samples was between 86.2% and 107.1, and the RSD was between 6.51% and 11.06, which proved that the aptamer sensor we constructed has excellent detection performance and practical application value in complex samples.
[0059] The specific samples and test results are shown in Table 2:
[0060] Table 2. Actual sample test table
[0061]
[0062] The above are all preferred embodiments of the present invention. For ordinary technicians in this technical field, without departing from the principle of the present invention, various equivalent modifications to the present invention belong to the protection scope of the claims attached to this application.
Claims
1. A fluorescent aptamer sensor for detecting kanamycin content, characterized in that: The fluorescent aptamer sensor includes two kanamycin split aptamers as recognition probes, ExoⅠ as a quencher, and detecting the fluorescence signal changes of different target concentrations after synthesizing the signal probe DNA silver nanocluster DNA-AgNCs. The complementary sequence cDNA of the kanamycin split aptamer Split-Apt-Ⅰ is specifically: CCTCCTTCTCCCGTACCCCCAA; The preparation method comprises the following steps: S1: Hybridization complementation between Split-Apt-Ⅰ sequence and cDNA-AgNCs sequence: cDNA-AgNCs sequence and Split-Apt-Ⅰ sequence are mixed and reacted, dissolved in an appropriate amount of buffer to form a dsDNA structure; S2: Recognition reaction between Split-Apt-Ⅰ, Split-Apt-Ⅱ and kanamycin: Split-Apt-Ⅱ is dissolved in an appropriate amount of buffer, heated in a metal bath, and then transferred to the above dsDNA solution, and diluted kanamycin solution is added for co-incubation; S3: Enzyme digestion reaction of ExoⅠ: add an appropriate amount of ExoⅠ to the above solution for enzyme digestion, inactivate the enzyme at high temperature after the reaction, and then cool it down in an ice bath; S4: Preparation of DNA-AgNCs signal probe: Add a certain amount of silver nitrate AgNO3 solution to the above solution, shake and mix, add an equal amount of sodium borohydride NaBH4 solution to trigger the chemical reduction reaction, shake and react in the dark to obtain the DNA-AgNCs signal probe.
2. The fluorescent aptamer sensor for detecting kanamycin content according to claim 1, characterized in that: The digestion temperature of ExoⅠ is 37°C, the digestion time is 35 min, and the dosage of DNA-AgNCs is 1.4 μmol / L.
3. The fluorescent aptamer sensor for detecting kanamycin content according to claim 1, characterized in that: The pH of the reaction system buffer was 6.
75.
4. The fluorescent aptamer sensor for detecting kanamycin content according to claim 1, characterized in that: The initial concentrations of Split-Apt-Ⅰ, Split-Apt-Ⅱ and cDNA-AgNCs sequences in S2 were 100 μmol / L, and kanamycin was added and mixed for incubation for 40 min.
5. The fluorescent aptamer sensor for detecting kanamycin content according to claim 1, characterized in that: In S3, the reaction temperature of ExoⅠ digestion was 37℃, the reaction time of ExoⅠ digestion was 35min, and the enzyme was inactivated by heating at 80℃ for 5min.
6. The fluorescent aptamer sensor for detecting kanamycin content according to claim 1, characterized in that: The pH of the buffer used in S4 is 6.75, and the concentration ratio of DNA substrate to AgNO3 and NaBH4 is 1:6:
6.
7. The fluorescent aptamer sensor for detecting kanamycin content according to claim 1, characterized in that: The concentration of kanamycin is 0nmol / L~10μmol / L.
8. The fluorescent aptamer sensor for detecting kanamycin content according to claim 1, characterized in that: After Split-Apt-Ⅰ and Split-Apt-Ⅱ in S1 are mixed evenly, denatured at 95℃ for 5 minutes, and then cooled down to renature slowly.
Citation Information
Patent Citations
Method for detecting antibiotics by fluorescence sensor based on aptamer
CN112011591A
DNA-AgNCs fluorescent aptamer sensor for detecting salmonella and application of DNA-AgNCs fluorescent aptamer sensor
CN114859045A
